128 related articles for article (PubMed ID: 9328331)
1. Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor.
Bertoletti A; Southwood S; Chesnut R; Sette A; Falco M; Ferrara GB; Penna A; Boni C; Fiaccadori F; Ferrari C
Hepatology; 1997 Oct; 26(4):1027-34. PubMed ID: 9328331
[TBL] [Abstract][Full Text] [Related]
2. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
3. The hepatitis B virus-specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection.
Livingston BD; Crimi C; Grey H; Ishioka G; Chisari FV; Fikes J; Grey H; Chesnut RW; Sette A
J Immunol; 1997 Aug; 159(3):1383-92. PubMed ID: 9233635
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytotoxic T lymphocyte responses induced by peptide or DNA immunization: implications on immunogenicity and immunodominance.
Vitiello A; Sette A; Yuan L; Farness P; Southwood S; Sidney J; Chesnut RW; Grey HM; Livingston B
Eur J Immunol; 1997 Mar; 27(3):671-8. PubMed ID: 9079808
[TBL] [Abstract][Full Text] [Related]
5. [Direct analysis of HBV-specific CD8+ lymphocyte by tetrameric HLA-A2/core 18-27 complex in chronic Hepatitis B].
Lee CK; Suh JH; Cho YS; Han KH; Chung JB; Chon CY; Moon YM
Taehan Kan Hakhoe Chi; 2002 Jun; 8(2):139-48. PubMed ID: 12499799
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
[TBL] [Abstract][Full Text] [Related]
8. Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.
Thimme R; Chang KM; Pemberton J; Sette A; Chisari FV
J Virol; 2001 Apr; 75(8):3984-7. PubMed ID: 11264388
[TBL] [Abstract][Full Text] [Related]
9. Human class I supertypes and CTL repertoires extend to chimpanzees.
Bertoni R; Sette A; Sidney J; Guidotti LG; Shapiro M; Purcell R; Chisari FV
J Immunol; 1998 Oct; 161(8):4447-55. PubMed ID: 9780224
[TBL] [Abstract][Full Text] [Related]
10. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].
Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781
[TBL] [Abstract][Full Text] [Related]
11. Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen.
Zaremba S; Barzaga E; Zhu M; Soares N; Tsang KY; Schlom J
Cancer Res; 1997 Oct; 57(20):4570-7. PubMed ID: 9377571
[TBL] [Abstract][Full Text] [Related]
12. Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.
Boni C; Penna A; Ogg GS; Bertoletti A; Pilli M; Cavallo C; Cavalli A; Urbani S; Boehme R; Panebianco R; Fiaccadori F; Ferrari C
Hepatology; 2001 Apr; 33(4):963-71. PubMed ID: 11283861
[TBL] [Abstract][Full Text] [Related]
13. The high prevalence of the I27 mutant HBcAg18-27 epitope in Chinese HBV-infected patients and its cross-reactivity with the V27 prototype epitope.
Liu HG; Chen WW; Fan ZP; Yang HY; Shi M; Zhang Z; Luan SS; Zhang H; Lu P; Tien P; Wang FS
Clin Immunol; 2007 Dec; 125(3):337-45. PubMed ID: 17900990
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of the CY-1899 T-cell vaccine in subjects chronically infected with hepatitis B virus. The CY1899 T Cell Vaccine Study Group.
Heathcote J; McHutchison J; Lee S; Tong M; Benner K; Minuk G; Wright T; Fikes J; Livingston B; Sette A; Chestnut R
Hepatology; 1999 Aug; 30(2):531-6. PubMed ID: 10421664
[TBL] [Abstract][Full Text] [Related]
15. The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise immunodominant HLA-A2-restricted epitope: implications for vaccine design.
Altfeld M; Allen TM; Kalife ET; Frahm N; Addo MM; Mothe BR; Rathod A; Reyor LL; Harlow J; Yu XG; Perkins B; Robinson LK; Sidney J; Alter G; Lichterfeld M; Sette A; Rosenberg ES; Goulder PJ; Brander C; Walker BD
J Virol; 2005 Apr; 79(8):5000-5. PubMed ID: 15795285
[TBL] [Abstract][Full Text] [Related]
16. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
[TBL] [Abstract][Full Text] [Related]
17. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
18. Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK; Leandersson AC; Devito C; Kohleisen B; Erfle V; Achour A; Levi M; Schwartz S; Kärre K; Wahren B; Hinkula J
Virology; 2000 Jul; 273(1):112-9. PubMed ID: 10891413
[TBL] [Abstract][Full Text] [Related]
19. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
Bondurant KL; Crew MD; Santin AD; O'Brien TJ; Cannon MJ
Clin Cancer Res; 2005 May; 11(9):3446-54. PubMed ID: 15867247
[TBL] [Abstract][Full Text] [Related]
20. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
